The Journal of Experimental Medicine
Rockland Immunochemicals for Research
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online April 30, 2007
doi:10.1084/jem.20052078
The Journal of Experimental Medicine, Vol. 204, No. 5, 971-977
The Rockefeller University Press, 0022-1007 $30.00
© 2007 Shi et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1251K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shi, L.
Right arrow Articles by Kao, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shi, L.
Right arrow Articles by Kao, P. N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

BRIEF DEFINITIVE REPORT

NF90 regulates inducible IL-2 gene expression in T cells

Lingfang Shi1, Wayne R. Godfrey2, Joseph Lin1, Guohua Zhao1, and Peter N. Kao1

1 Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, CA 94305
2 Cellular Immunology, Dendreon Corp., Seattle, WA 98121

CORRESPONDENCE Peter N. Kao: peterkao{at}stanford.edu

Activation of T cells induces the production of T cell growth and survival factor interleukin (IL) 2. Regulatory T cells intrinsically fail to induce IL-2 expression upon activation and can suppress IL-2 production in conventional T cells. Thus, the control of IL-2 expression is critically important to T cell immune responses, yet the mechanisms remain incompletely understood. Nuclear factor (NF) 90 is a zinc-finger DNA- and double-stranded RNA-binding protein subunit that binds specifically to the antigen receptor response element (ARRE)/NF of activated T cells target sequence in the IL-2 proximal promoter. Inducible binding of NF90 to the IL-2 promoter in vivo is shown by chromatin immunoprecipitation. NF90 gene-targeted mice exhibit perinatal lethality. Compared with newborn NF90+/+ mice, newborn NF90–/– mice demonstrate severe impairment of IL-2 expression. Compared with wild-type cells, T cells deficient in NF90 are impaired in ARRE and IL-2 transcriptional activation and IL-2 mRNA stabilization. Fetal liver cells from NF90 gene-targeted mice were transplanted into irradiated adult recombination activating gene (RAG)–2–/– and IL-2R{gamma}–/– mice deficient in T cells, B cells, and natural killer cells. NF90+/+- and NF90–/–-RAG chimeric mice showed grossly normal repopulation of the thymus and spleen, but only NF90–/– T cells were severely impaired in IL-2 gene expression. Compared with littermates, NF90–/– RAG chimeric mice exhibited profound T cell lymphocytopenia in the peripheral circulation. Thus, NF90 regulates inducible IL-2 transcription, mRNA stability, and gene expression in T cells and represents a novel therapeutic target for the modulation of T cell immune responses.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS